Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J, Lilly & Merck Reassure Investors About Medicare Reform Process

Executive Summary

The lessons from the health care reform debate in the mid-1990s will ensure a more "sensible" debate over health care in 2000, J&J CEO Ralph Larsen told analysts during a Jan. 25 conference call.

You may also be interested in...



Clinton Emphasizes Biomedical Research Over Rx Cost In State Of The Union

President Clinton's State of the Union message emphasized the value of biomedical research rather than the cost of drugs.

Propulsid Physician Education On Cardiac Risk To Be Presented To Committee

Janssen will detail professional education campaign plans for conveying cardiac risks associated with the nighttime heartburn treatment Propulsid (cisapride) at the April 12 FDA advisory committee review of the product's safety.

Clinton Emphasizes Biomedical Research Over Rx Cost In State Of The Union

President Clinton's State of the Union message emphasized the value of biomedical research rather than the cost of drugs.

UsernamePublicRestriction

Register

LL1134420

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel